ArticleFrontiers in oncology2022

Use of Nab-Paclitaxel Plus Gemcitabine Followed by Hypofractionated Tomotherapy With Simultaneous Integrated Boost in Patients With Locally Advanced Pancreatic Cancer.

Zhan Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.